The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Walgreens Hits the Road With Skin Cancer Foundation
May 17th 2018Walgreens is joining The Skin Cancer Foundation on the road this year in support of its Destination: Healthy Skin Program—a national effort to educate the public about the importance of effective sun protection for skin cancer prevention, and the importance of early detection.
Read More
FDA Approves First Epoetin Alfa Biosimilar for Anemia Treatment
May 16th 2018The FDA today approved epoetin alfa-epbx (Retacrit) as a biosimilar to epoetin alfa (Epogen/Procrit) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection
Read More